Release Date: 27/08/09 13:54 Summary: 2009 Annual Results Presentation Price Sensitive: No Download Document 583.34KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%